Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Natco Gets Favourable Ruling in US

Natco Gets Favourable Ruling in US

Chemical Weekly 2018-04-25

Hyderabad-based Natco Pharma Ltd. has been awarded a favourable judgment in the US Court of Appeals for the Federal Circuit ruling on patent-related to Teva’s Copaxone (treat multiple sclerosis). The court of appeals had reversed a district court’s finding related to Copaxone patent.

“This would essentially mean that Natco could launch the generic version of Copaxone through its marketing partner Mylan Inc during May 2014 subject to FDA approval,” the company said in a release.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.